Cozad Stacy 4

What Happened
Stacy Cozad, Executive Vice President and Chief Legal Officer of Xylem Inc., received equity compensation on 2026-03-02 consisting of 1,563 restricted stock units (RSUs) and a grant of 5,570 non-qualified stock options. The option grant is reported with a grant-date price of $128.98 per share, giving a reported derivative award value of $718,419. The RSUs show $0 purchase price because they are awards that will vest over time rather than an immediate cash purchase.

Key Details

• Transaction date: 2026-03-02; Form 4 filed 2026-03-03 (appears timely).
• RSUs: 1,563 shares @ $0.00 (award). These RSUs are scheduled to vest in three equal annual tranches on March 1, 2027; March 1, 2028; and March 1, 2029 (Footnote F1).
• Options: 5,570 non-qualified stock options @ $128.98 (derivative award) with reported value $718,419. Options vest in three equal tranches on March 1, 2027; March 1, 2028; and March 1, 2029 (Footnote F2).
• Shares owned after the transaction: not provided in the information supplied.
• Filing appears timely (filed the next day); no 10b5-1 plan or tax-withholding notes included in the supplied excerpt.

Context
These grants are compensation awards, not open-market purchases or sales. RSUs and options vest over future dates, so they do not represent immediately tradable shares. Such awards are common for executive pay and are intended to align management incentives with shareholder value over time.